Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Plasma Epstein–Barr virus"'
Autor:
Sai-Lan Liu, Xiao-Yun Li, Xue-Song Sun, Jing-Yun Peng, Chao Lin, Jin-Jie Yan, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Li-Ting Liu, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Purpose To analyze the clinical outcomes of patients with regional persistent/recurrent nasopharyngeal carcinoma (NPC) who received neck dissection, and to evaluate the clinical benefit of postoperative adjuvant therapy (PAT) based on patien
Externí odkaz:
https://doaj.org/article/8526add604294940b4931849109b754b
Autor:
K. V. Smirnova, N. B. Senuta, I. V. Botezatu, A. V. Ignatova, T. E. Dushenkina, A. A. Zolotarev, A. V. Lichtenstein, V. E. Gurtsevich
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 3, Pp 14-24 (2021)
Introduction. Epstein–Barr virus (EBV) is equally widespread in the endemic and non-endemic world regions for nasopharyngeal cancer (NPC). High incidence of NPC in endemic countries and low in non-endemic countries suggest there are different mecha
Externí odkaz:
https://doaj.org/article/10bee2d47671466f9d54ff67011fb776
Autor:
Sai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, Qiu-Yan Chen, Huan-Xin Lin, Hu Liang, Yu-Jing Liang, Xiao-Yun Li, Jin-Jie Yan, Chao Lin, Zhen-Chong Yang, Shan-Shan Guo, Li-Ting Liu, Qing-Nan Tang, Yu-Yun Du, Lin-Quan Tang, Ling Guo, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background We compared the efficacy and toxicity of three IC regimens (TPF: taxanes, cisplatin, and 5-fluorouracil; TP: taxanes and cisplatin; and PF: cisplatin and 5-fluorouracil) followed by CCRT in locoregionally advanced NPC. Methods The
Externí odkaz:
https://doaj.org/article/eb027476d81c4c98a703d19a403b9f74
Autor:
Sik-Kwan Chan, Sum-Yin Chan, Horace Cheuk-Wai Choi, Chi-Chung Tong, Ka-On Lam, Dora Lai-Wan Kwong, Varut Vardhanabhuti, To-Wai Leung, Mai-Yee Luk, Anne Wing-Mui Lee, Victor Ho-Fun Lee
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Introduction: The prognostic role of plasma Epstein–Barr virus (EBV) DNA clearance when intensity-modulated radiotherapy (IMRT) and the 8th edition of American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) TNM Stagi
Externí odkaz:
https://doaj.org/article/c3724f004dbb446880ac0f107ba4e9f3
Autor:
Yu Jing Liang, Xiao Yun Li, Lin Quan Tang, Shan Shan Guo, Ling Guo, Xue Song Sun, Sai Lan Liu, Li Ting Liu, Hu Liang, Jin Jie Yan, Zhen Chong Yang, Hao Jun Xie, Huan Xin Lin, Qiu Yan Chen, Hai Qiang Mai, Yu Yun Du, Qing Nan Tang, Chao Lin
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Cancer
BMC Cancer
Background We compared the efficacy and toxicity of three IC regimens (TPF: taxanes, cisplatin, and 5-fluorouracil; TP: taxanes and cisplatin; and PF: cisplatin and 5-fluorouracil) followed by CCRT in locoregionally advanced NPC. Methods The retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056d2429a7b779e98a9d605edfe203c7
https://doaj.org/article/eb027476d81c4c98a703d19a403b9f74
https://doaj.org/article/eb027476d81c4c98a703d19a403b9f74
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shaobo Liang, Di Dong, Lianzhen Zhong, Jie Tian, Xue-Liang Fang, Ning Zhang, Jun Ma, Hong Shan, Runnan Cao, Fan Zhang, Cong Li, Mengjie Fang, Liwen Zhang, Ling-Long Tang, Yujia Liu, Xun Zhao, Zhenhua Hu, Wei Jiang
Publikováno v:
EBioMedicine, Vol 70, Iss, Pp 103522-(2021)
EBioMedicine
EBioMedicine
Background: Induction chemotherapy (ICT) plus concurrent chemoradiotherapy (CCRT) and CCRT alone were the optional treatment regimens in locoregionally advanced nasopharyngeal carcinoma (NPC) patients. Currently, the choice of them remains equivocal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703cfead5bdd92f612505437b28b60ca
http://www.sciencedirect.com/science/article/pii/S2352396421003157
http://www.sciencedirect.com/science/article/pii/S2352396421003157
Autor:
Horace Cheuk Wai Choi, Dora L.W. Kwong, Varut Vardhanabhuti, Anne Wing-Mui Lee, Sum-Yin Chan, Ka-On Lam, Victor Ho-Fun Lee, Mai-Yee Luk, To-Wai Leung, Sik-Kwan Chan, Chi-Chung Tong
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Introduction: The prognostic role of plasma Epstein–Barr virus (EBV) DNA clearance when intensity-modulated radiotherapy (IMRT) and the 8th edition of American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) TNM Stagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067d5a7d146c2669292be44b6ba74ee1
https://doi.org/10.3389/fonc.2020.01417
https://doi.org/10.3389/fonc.2020.01417
Autor:
Wei-Jie Luo, Yuan Zhang, Ying Sun, Jun Ma, Cheng-Long Huang, Ling-Long Tang, Jun-Yan Li, Yu Pei Chen, Hao Peng
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Few studies have evaluated the prognostic value of the integrated model consisting of gross tumor volume of lymph nodes (GTVnd) and pretreatment plasma Epstein–Barr virus DNA (pre-EBV DNA) in nasopharyngeal carcinoma (NPC) patients. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed001c5f4f130dd94a2f50ec157be6fc
http://europepmc.org/articles/PMC6763945
http://europepmc.org/articles/PMC6763945
Autor:
Jin Ching Lin, Hsiao Hui Tsou, Wen-Yi Wang, Yi Chun Liu, Po Ju Lin, He Yuan Hsieh, Chih Wen Twu, Tian Yun Lin, Jing Wen Huang
Publikováno v:
Oncotarget
// Wen-Yi Wang 1, 2, * , Tian-Yun Lin 3, * , Chih-Wen Twu 4, 5 , Hsiao-Hui Tsou 6, 7 , Po-Ju Lin 8 , Yi-Chun Liu 8 , Jing-Wen Huang 8 , He-Yuan Hsieh 8 , Jin-Ching Lin 5, 8, 9, 10 1 Department of Nursing, Hung Kuang University, Taichung, Taiwan 2 Dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef3bb796264444a2cfec29de7ecf6401
http://europepmc.org/articles/PMC5173160
http://europepmc.org/articles/PMC5173160